- Home
- TIL vs MBOT Comparison
TIL vs MBOT Comparison
Compare TIL & MBOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TIL
- MBOT
- Stock Information
- Founded
- TIL 2018
- MBOT 2010
- Country
- TIL United States
- MBOT United States
- Employees
- TIL N/A
- MBOT N/A
- Industry
- TIL Biotechnology: Pharmaceutical Preparations
- MBOT Medical/Dental Instruments
- Sector
- TIL Health Care
- MBOT Health Care
- Exchange
- TIL Nasdaq
- MBOT Nasdaq
- Market Cap
- TIL 177.1M
- MBOT 184.8M
- IPO Year
- TIL 2021
- MBOT N/A
- Fundamental
- Price
- TIL $21.03
- MBOT $3.09
- Analyst Decision
- TIL Buy
- MBOT Strong Buy
- Analyst Count
- TIL 6
- MBOT 1
- Target Price
- TIL $120.50
- MBOT $12.00
- AVG Volume (30 Days)
- TIL 150.1K
- MBOT 7.3M
- Earning Date
- TIL 11-12-2025
- MBOT 11-12-2025
- Dividend Yield
- TIL N/A
- MBOT N/A
- EPS Growth
- TIL N/A
- MBOT N/A
- EPS
- TIL N/A
- MBOT N/A
- Revenue
- TIL N/A
- MBOT N/A
- Revenue This Year
- TIL N/A
- MBOT N/A
- Revenue Next Year
- TIL N/A
- MBOT $728.02
- P/E Ratio
- TIL N/A
- MBOT N/A
- Revenue Growth
- TIL N/A
- MBOT N/A
- 52 Week Low
- TIL $10.80
- MBOT $0.85
- 52 Week High
- TIL $73.69
- MBOT $4.67
- Technical
- Relative Strength Index (RSI)
- TIL 37.54
- MBOT 43.65
- Support Level
- TIL $20.11
- MBOT $3.25
- Resistance Level
- TIL $25.89
- MBOT $4.25
- Average True Range (ATR)
- TIL 2.57
- MBOT 0.42
- MACD
- TIL -0.69
- MBOT -0.11
- Stochastic Oscillator
- TIL 6.70
- MBOT 1.86
About TIL Instil Bio Inc.
Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.
About MBOT Microbot Medical Inc.
Microbot Medical Inc is a clinical-stage medical device company specializing in the research, design and development of next-generation robotic endoluminal surgery devices targeting the minimally invasive surgery space. It is focused on leveraging its robotic technologies to redefine surgical robotics while improving surgical outcomes for patients. Using its LIBERTY technological platform, the company is developing the first-ever fully disposable robot for various endovascular interventional procedures.